ArticleOncotarget2016

Bromodomain inhibitor OTX015 (MK-8628) combined with targeted agents shows strong in vivo antitumor activity in lymphoma.

Eugenio Gaudio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.